Anabolic Strategies to Augment Bone Fracture Healing

por Roberts, Scott J., Ke, Hua Zhu
Publicado 2018

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats

por Agholme, Fredrik, Isaksson, Hanna, Li, Xiaodong, Ke, Hua Zhu, Aspenberg, Per
Publicado 2011

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis

por Chen, Xiao-Xiang, Baum, Wolfgang, Dwyer, Denise, Stock, Michael, Schwabe, Kay, Ke, Hua-Zhu, Stolina, Marina, Schett, Georg, Bozec, Aline
Publicado 2013

IL-1 receptor–associated kinase M is a central regulator of osteoclast differentiation and activation

por Li, Hongmei, Cuartas, Esteban, Cui, Weiguo, Choi, Yongwon, Crawford, Todd D., Ke, Hua Zhu, Kobayashi, Koichi S., Flavell, Richard A., Vignery, Agnès
Publicado 2005

Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis

por Dreyer, Timothy, Shah, Mittal, Doyle, Carl, Greenslade, Kevin, Penney, Mark, Creeke, Paul, Kotian, Apoorva, Ke, Hua Zhu, Naidoo, Vinny, Holdsworth, Gill
Publicado 2021

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

por Florio, Monica, Gunasekaran, Kannan, Stolina, Marina, Li, Xiaodong, Liu, Ling, Tipton, Barbara, Salimi-Moosavi, Hossein, Asuncion, Franklin J., Li, Chaoyang, Sun, Banghua, Tan, Hong Lin, Zhang, Li, Han, Chun-Ya, Case, Ryan, Duguay, Amy N., Grisanti, Mario, Stevens, Jennitte, Pretorius, James K., Pacheco, Efrain, Jones, Heidi, Chen, Qing, Soriano, Brian D., Wen, Jie, Heron, Brenda, Jacobsen, Frederick W., Brisan, Emil, Richards, William G., Ke, Hua Zhu, Ominsky, Michael S.
Publicado 2016